International Journal For Multidisciplinary Research

E-ISSN: 2582-2160     Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 8, Issue 2 (March-April 2026) Submit your research before last 3 days of April to publish your research paper in the issue of March-April.

Can Empathy be Scaled? Rethinking Patient-centric Pharma Marketing in the Age of Artificial Intelligence

Author(s) Mr. ABHINAV SHARMA
Country India
Abstract Artificial intelligence (AI) is transforming pharmaceutical marketing by enabling data-driven personalization, predictive engagement, and scalable communication strategies. These advancements have significantly improved efficiency and reach, particularly in increasingly digital and omnichannel healthcare ecosystems. However, healthcare communication operates within a uniquely sensitive context where trust, vulnerability, and ethical responsibility are central.
Despite the industry’s growing emphasis on patient-centricity, there remains a critical gap between technological capability and emotional resonance. AI-driven systems often prioritize optimization and behavioral targeting, risking the reduction of patients to data points rather than individuals with lived experiences. This creates a fundamental tension between scale and empathy in pharmaceutical marketing.
As the industry moves toward algorithmic engagement models, it becomes essential to examine whether empathy traditionally human, relational, and context-dependent can be preserved, designed, and scaled within AI-enabled frameworks without compromising authenticity, dignity, or trust.
Keywords Patient-centric marketing, empathy, artificial intelligence, pharmaceutical marketing, ethical AI, patient experience, personalization, healthcare marketing
Field Business Administration
Published In Volume 8, Issue 2, March-April 2026
Published On 2026-04-01
DOI https://doi.org/10.36948/ijfmr.2026.v08i02.73193

Share this